Goldman Sachs
DXTR

Goldman Sachs’s Dextera Surgical Inc. DXTR Stock Holding History

Goldman Sachs’s Portfolio DXTR Stock Details DXTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,732
Closed -$4K – 6908
2017
Q3 		$4K Buy
13,732
+149
+1% +$43 ﹤0.01% 6592
2017
Q2 		$4K Buy
+13,583
New +$6.87K ﹤0.01% 6712

Other funds holding DXTR

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Goldman Sachs's DXTR Position: Q4 2017 in Review

Goldman Sachs sold out of Dextera Surgical Inc. (DXTR) in Q4 2017, closing a stake of 13,732 shares — an estimated $4K sold.

Goldman Sachs first reported a position in DXTR in Q2 2017 and held it in 2 quarters. The position peaked at $4K in Q3 2017. 3 funds tracked by Wall St. Rank hold DXTR as of Q4 2017.

  • Goldman Sachs reported no remaining Dextera Surgical Inc. position as of Q4 2017 after selling out during the quarter.
  • Goldman Sachs sold 13,732 Dextera Surgical Inc. shares in Q4 2017, an estimated $4K.
  • Goldman Sachs first reported a position in Dextera Surgical Inc. in Q2 2017 and held it in 2 quarters.
  • Goldman Sachs's Dextera Surgical Inc. position peaked at $4K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Dextera Surgical Inc. as of Q4 2017.

Based on Goldman Sachs's 13F filing for Q4 2017, filed 14 Feb 2018.